Business

Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

Management will participate in three upcoming investor healthcare conferencesSALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings conference call at 4:30 pm ET on Monday, Feb. 23, 2026. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and busines

articleMyriad Genetics, Inc.February 16, 20262/company/myriad-genetics-inc/news/myriad-genetics-release-fourth-quarter-211500302
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

About this update from Myriad Genetics, Inc.

[{"type":"image","alt":"Myriad Genetics, Inc.","displaySize":"","headline":null,"caption":"Myriad Genetics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":138,"url":"https://media.zenfs.com/en/globenewswire.com/d43f1e89209f6724a2684841f43efbbf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_y5LWpbQjZzzOJzKUH_nTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/d43f1e89209f6724a2684841f43efbbf","width":300,"height":138}},"lazy":false},{"type":"text","content":"Management will participate in three upcoming investor healthcare conferences","length":77,"tagName":"p"},{"type":"text","content":"SALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings conference call at 4:30 pm ET on Monday, Feb. 23, 2026. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the fourth quarter and full year 2025.","length":503,"tagName":"p"},{"type":"text","content":"A live webcast of the earnings conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.","length":394,"tagName":"p"},{"type":"text","content":"Upcoming Investor ConferencesSam Raha, President and CEO, and Ben Wheeler, Chief Financial Officer, will participate in the following investor healthcare conferences:","length":167,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The TD Cowen 46th Annual Health Care Conference in a fireside chat at 3:10 pm ET on Tuesday, March 3, 2026.","length":107,"tagName":"p"}]},{"val":[{"type":"text","content":"The Leerink Partners Global Healthcare Conference in a fireside chat at 1:40 pm ET on Tuesday, March 10, 2026.","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"The Barclays 28th Annual Global Healthcare conference in 1-on-1 meetings on Wednesday, March...

More updates from Myriad Genetics, Inc.

Myriad Geneticsquarterly earningsInvestor ConferencesLeerink PartnersInvestor Relations websiteGlobal Healthcare conferenceconference call